nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—MAPK3—PDGFR-beta signaling pathway—PDGFB—meningioma	0.00424	0.00424	CbGpPWpGaD
Sulindac—MAPK3—Alpha 6 Beta 4 signaling pathway—AKT1—meningioma	0.00405	0.00405	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—HES1—meningioma	0.00405	0.00405	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—PTEN—meningioma	0.00399	0.00399	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—ERBB2—meningioma	0.00398	0.00398	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00389	0.00389	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—PDGFB—meningioma	0.00385	0.00385	CbGpPWpGaD
Sulindac—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—meningioma	0.00381	0.00381	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—meningioma	0.00371	0.00371	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—PDGFB—meningioma	0.00368	0.00368	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—PDGFB—meningioma	0.00368	0.00368	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—PDGFB—meningioma	0.00362	0.00362	CbGpPWpGaD
Sulindac—MAPK3—CXCR3-mediated signaling events—AKT1—meningioma	0.00362	0.00362	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ALAD—meningioma	0.00358	0.00358	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00356	0.00356	CbGpPWpGaD
Sulindac—MAPK3—IL-5 Signaling Pathway—AKT1—meningioma	0.00347	0.00347	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—PDGFB—meningioma	0.00346	0.00346	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—PDGFB—meningioma	0.00344	0.00344	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TSHB—meningioma	0.00343	0.00343	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—PDGFB—meningioma	0.00343	0.00343	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—PDGFB—meningioma	0.00341	0.00341	CbGpPWpGaD
Sulindac—MAPK3—ErbB2/ErbB3 signaling events—AKT1—meningioma	0.0034	0.0034	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—PTEN—meningioma	0.00339	0.00339	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—PDGFB—meningioma	0.00334	0.00334	CbGpPWpGaD
Sulindac—MAPK3—TWEAK Signaling Pathway—AKT1—meningioma	0.00334	0.00334	CbGpPWpGaD
Sulindac—MAPK3—IL-2 Signaling Pathway—AKT1—meningioma	0.00334	0.00334	CbGpPWpGaD
Sulindac—MAPK3—IL-6 signaling pathway—AKT1—meningioma	0.00328	0.00328	CbGpPWpGaD
Sulindac—MAPK3—IFN-gamma pathway—AKT1—meningioma	0.00328	0.00328	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—AKT1—meningioma	0.00322	0.00322	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—PDGFB—meningioma	0.00321	0.00321	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—PDGFB—meningioma	0.00321	0.00321	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—PDGFB—meningioma	0.00321	0.00321	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.0032	0.0032	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—PDGFB—meningioma	0.00318	0.00318	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—PDGFB—meningioma	0.00315	0.00315	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—PDGFB—meningioma	0.00314	0.00314	CbGpPWpGaD
Sulindac—MAPK3—TSLP Signaling Pathway—AKT1—meningioma	0.00305	0.00305	CbGpPWpGaD
Sulindac—MAPK3—Ceramide signaling pathway—AKT1—meningioma	0.003	0.003	CbGpPWpGaD
Sulindac—MAPK3—IL-3 Signaling Pathway—AKT1—meningioma	0.00295	0.00295	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SMO—meningioma	0.00292	0.00292	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—PDGFB—meningioma	0.00291	0.00291	CbGpPWpGaD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—AKT1—meningioma	0.0029	0.0029	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—meningioma	0.00286	0.00286	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—PDGFB—meningioma	0.00284	0.00284	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PGR—meningioma	0.0028	0.0028	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—TP53—meningioma	0.00279	0.00279	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—meningioma	0.00277	0.00277	CbGpPWpGaD
Sulindac—MAPK3—IL-4 Signaling Pathway—AKT1—meningioma	0.00273	0.00273	CbGpPWpGaD
Sulindac—MAPK3—FGF signaling pathway—AKT1—meningioma	0.00273	0.00273	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—TP53—meningioma	0.00272	0.00272	CbGpPWpGaD
Sulindac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—meningioma	0.00272	0.00272	CbGpPWpGaD
Sulindac—MAPK3—Cardiac Hypertrophic Response—AKT1—meningioma	0.00269	0.00269	CbGpPWpGaD
Sulindac—MAPK3—IL-1 signaling pathway—AKT1—meningioma	0.00269	0.00269	CbGpPWpGaD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.00269	0.00269	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00268	0.00268	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CTSL—meningioma	0.00268	0.00268	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—ERBB2—meningioma	0.00258	0.00258	CbGpPWpGaD
Sulindac—MAPK3—Kit receptor signaling pathway—AKT1—meningioma	0.00254	0.00254	CbGpPWpGaD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—AKT1—meningioma	0.00248	0.00248	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00247	0.00247	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—ERBB2—meningioma	0.00243	0.00243	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AP1B1—meningioma	0.00242	0.00242	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—PTEN—meningioma	0.00242	0.00242	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—PGR—meningioma	0.00242	0.00242	CbGpPWpGaD
Sulindac—MAPK3—Integrins in angiogenesis—AKT1—meningioma	0.00241	0.00241	CbGpPWpGaD
Sulindac—MAPK3—Endothelins—AKT1—meningioma	0.00241	0.00241	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TP53—meningioma	0.00238	0.00238	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00235	0.00235	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—AKT1—meningioma	0.00233	0.00233	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—AKT1—meningioma	0.00233	0.00233	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—AKT1—meningioma	0.00233	0.00233	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—ERBB2—meningioma	0.00232	0.00232	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—TP53—meningioma	0.00231	0.00231	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—TP53—meningioma	0.00231	0.00231	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—ERBB2—meningioma	0.00231	0.00231	CbGpPWpGaD
Sulindac—PPARD—Metabolism—TSHB—meningioma	0.00231	0.00231	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—AKT1—meningioma	0.0023	0.0023	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	0.0023	0.0023	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—ERBB2—meningioma	0.0023	0.0023	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—ERBB2—meningioma	0.00228	0.00228	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—AKT1—meningioma	0.00227	0.00227	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—meningioma	0.00227	0.00227	CbGpPWpGaD
Sulindac—MAPK3—Disease—AP1B1—meningioma	0.00224	0.00224	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—PTEN—meningioma	0.0022	0.0022	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—PDGFB—meningioma	0.00218	0.00218	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00215	0.00215	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—ERBB2—meningioma	0.00215	0.00215	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—ERBB2—meningioma	0.00215	0.00215	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—ERBB2—meningioma	0.00213	0.00213	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TP53—meningioma	0.00213	0.00213	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00211	0.00211	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—PTEN—meningioma	0.0021	0.0021	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—ERBB2—meningioma	0.0021	0.0021	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—AKT1—meningioma	0.0021	0.0021	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—PTEN—meningioma	0.00207	0.00207	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00202	0.00202	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—meningioma	0.00199	0.00199	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—PTEN—meningioma	0.00199	0.00199	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—PTEN—meningioma	0.00198	0.00198	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—PTEN—meningioma	0.00197	0.00197	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—PTEN—meningioma	0.00196	0.00196	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—AKT1—meningioma	0.00195	0.00195	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—AKT1—meningioma	0.00195	0.00195	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—PTEN—meningioma	0.00195	0.00195	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00192	0.00192	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—PLAUR—meningioma	0.00191	0.00191	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HES1—meningioma	0.00191	0.00191	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.0019	0.0019	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—PTEN—meningioma	0.00183	0.00183	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00183	0.00183	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—PTEN—meningioma	0.00183	0.00183	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—PTEN—meningioma	0.00182	0.00182	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—AKT1—meningioma	0.00181	0.00181	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—PTEN—meningioma	0.0018	0.0018	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—PTEN—meningioma	0.00179	0.00179	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—AKT1—meningioma	0.00178	0.00178	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—AKT1—meningioma	0.00178	0.00178	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—PTEN—meningioma	0.00173	0.00173	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—meningioma	0.00173	0.00173	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00172	0.00172	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—meningioma	0.00172	0.00172	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TSHB—meningioma	0.00167	0.00167	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—HES1—meningioma	0.00165	0.00165	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00164	0.00164	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD34—meningioma	0.00164	0.00164	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PDGFB—meningioma	0.00163	0.00163	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00162	0.00162	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—AKT1—meningioma	0.0016	0.0016	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.00158	0.00158	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTSL—meningioma	0.00156	0.00156	CbGpPWpGaD
Sulindac—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.00155	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—AKT1—meningioma	0.00149	0.00149	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—ERBB2—meningioma	0.00146	0.00146	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—SMO—meningioma	0.00142	0.00142	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00141	0.00141	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—PDGFB—meningioma	0.00138	0.00138	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALAD—meningioma	0.00137	0.00137	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—PLAU—meningioma	0.00134	0.00134	CbGpPWpGaD
Sulindac—PTGS2—Disease—AP1B1—meningioma	0.00133	0.00133	CbGpPWpGaD
Sulindac—MAPK3—Disease—CST3—meningioma	0.00133	0.00133	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—ERBB2—meningioma	0.00133	0.00133	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—meningioma	0.00132	0.00132	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—meningioma	0.0013	0.0013	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00129	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00128	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—AKT1—meningioma	0.00127	0.00127	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—PTEN—meningioma	0.00125	0.00125	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—PDGFB—meningioma	0.00125	0.00125	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—AKT1—meningioma	0.00125	0.00125	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PGR—meningioma	0.00123	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—AKT1—meningioma	0.00121	0.00121	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.0012	0.0012	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—meningioma	0.0012	0.0012	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—AKT1—meningioma	0.00119	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00118	0.00118	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—AKT1—meningioma	0.00115	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—AKT1—meningioma	0.00114	0.00114	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—AKT1—meningioma	0.00113	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—AKT1—meningioma	0.00113	0.00113	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—AKT1—meningioma	0.00112	0.00112	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—AKT1—meningioma	0.0011	0.0011	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ERBB2—meningioma	0.0011	0.0011	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALAD—meningioma	0.00109	0.00109	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—AKT1—meningioma	0.00106	0.00106	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—AKT1—meningioma	0.00106	0.00106	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.00106	0.00106	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—AKT1—meningioma	0.00105	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—AKT1—meningioma	0.00104	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—AKT1—meningioma	0.00103	0.00103	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—meningioma	0.00103	0.00103	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00103	0.00103	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—AKT1—meningioma	0.001	0.001	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—AKT1—meningioma	0.000999	0.000999	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000994	0.000994	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TSHB—meningioma	0.000984	0.000984	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALAD—meningioma	0.000964	0.000964	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—ERBB2—meningioma	0.000946	0.000946	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000936	0.000936	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PTEN—meningioma	0.000934	0.000934	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PLAUR—meningioma	0.000921	0.000921	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—AKT1—meningioma	0.000912	0.000912	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—meningioma	0.000908	0.000908	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000884	0.000884	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TSHB—meningioma	0.000882	0.000882	CbGpPWpGaD
Sulindac—ALB—Metabolism—ALAD—meningioma	0.000879	0.000879	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SMO—meningioma	0.000837	0.000837	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—ERBB2—meningioma	0.000835	0.000835	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PGR—meningioma	0.000802	0.000802	CbGpPWpGaD
Sulindac—PTGS2—Disease—CST3—meningioma	0.000792	0.000792	CbGpPWpGaD
Sulindac—MAPK3—Disease—HES1—meningioma	0.000783	0.000783	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PDGFB—meningioma	0.000726	0.000726	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—AKT1—meningioma	0.00072	0.00072	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—PTEN—meningioma	0.000712	0.000712	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TSHB—meningioma	0.0007	0.0007	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.0007	0.0007	CbGpPWpGaD
Sulindac—MAPK3—Disease—PDGFB—meningioma	0.00067	0.00067	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PDGFB—meningioma	0.000666	0.000666	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PLAU—meningioma	0.000646	0.000646	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—meningioma	0.000638	0.000638	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTEN—meningioma	0.000628	0.000628	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TSHB—meningioma	0.000621	0.000621	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALAD—meningioma	0.000615	0.000615	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000591	0.000591	CbGpPWpGaD
Sulindac—ALB—Metabolism—TSHB—meningioma	0.000566	0.000566	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HES1—meningioma	0.000549	0.000549	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—meningioma	0.00054	0.00054	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000539	0.000539	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AKT1—meningioma	0.000539	0.000539	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—meningioma	0.000509	0.000509	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ERBB2—meningioma	0.000486	0.000486	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PDGFB—meningioma	0.000469	0.000469	CbGpPWpGaD
Sulindac—PTGS2—Disease—HES1—meningioma	0.000466	0.000466	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—AKT1—meningioma	0.000466	0.000466	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—AKT1—meningioma	0.000465	0.000465	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—AKT1—meningioma	0.000456	0.000456	CbGpPWpGaD
Sulindac—MAPK3—Disease—ERBB2—meningioma	0.000449	0.000449	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000428	0.000428	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000425	0.000425	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PTEN—meningioma	0.000415	0.000415	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—AKT1—meningioma	0.00041	0.00041	CbGpPWpGaD
Sulindac—PTGS2—Disease—PDGFB—meningioma	0.000398	0.000398	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TSHB—meningioma	0.000396	0.000396	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTEN—meningioma	0.000383	0.000383	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00038	0.00038	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AKT1—meningioma	0.000362	0.000362	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000346	0.000346	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ERBB2—meningioma	0.000314	0.000314	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTEN—meningioma	0.000268	0.000268	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERBB2—meningioma	0.000267	0.000267	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AKT1—meningioma	0.000262	0.000262	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—meningioma	0.00026	0.00026	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000242	0.000242	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTEN—meningioma	0.00024	0.00024	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AKT1—meningioma	0.000239	0.000239	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—AKT1—meningioma	0.000238	0.000238	CbGpPWpGaD
Sulindac—PTGS2—Disease—PTEN—meningioma	0.000228	0.000228	CbGpPWpGaD
Sulindac—MAPK3—Disease—AKT1—meningioma	0.000221	0.000221	CbGpPWpGaD
Sulindac—ALB—Hemostasis—AKT1—meningioma	0.000219	0.000219	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PTEN—meningioma	0.000191	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—meningioma	0.000183	0.000183	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTEN—meningioma	0.000169	0.000169	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT1—meningioma	0.000155	0.000155	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTEN—meningioma	0.000154	0.000154	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AKT1—meningioma	0.000138	0.000138	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT1—meningioma	0.000131	0.000131	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AKT1—meningioma	0.00011	0.00011	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTEN—meningioma	0.000108	0.000108	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AKT1—meningioma	9.75e-05	9.75e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—AKT1—meningioma	8.89e-05	8.89e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKT1—meningioma	6.22e-05	6.22e-05	CbGpPWpGaD
